Adjuvant lapatinib in women with early-stage HER2-positive breast cancer (HER2+BC): Analysis of the hormone receptor-negative subgroup of the intent-to-treat (ITT) population of the TEACH trial. Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Smith, Ian Edward
  • Finkelstein, Dianne M
  • O'Shaughnessy, Joyce
  • Moy, Beverly
  • Ejlertsen, Bent
  • Kaufmann, Manfred
  • Buzdar, Aman
  • Fumoleau, Pierre
  • Gradishar, William John
  • Martin, Miguel
  • Boyle, Frances
  • Piccart-Gebhart, Martine J
  • Pritchard, Kathleen
  • Lindquist, Deborah
  • Rappold, Erica
  • Williams, Lisa Simone
  • Liedke, Pedro ER
  • Chavarri-Guerra, Yanin
  • Goss, Paul Edward

publication date

  • May 20, 2012